Hofseth Biocare ASA operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hofseth Biocare ASA with three other
pharmaceutical manufacturers in Europe:
Nuevolution AB (publ)
sales of 21.31 million Swedish Kronor [US$2.42 million]
Premier Veterinary Group PLC
of the United Kingdom
(£2.99 million [US$3.69 million]
based in the United Kingdom
(£2.65 million [US$3.27 million]
of which 54%
During the year ended December of 2016, sales at
Hofseth Biocare ASA were NOK 20.20 million (US$2.38 million).
decrease of 37.1%
versus 2015, when the company's sales were NOK 32.14 million.